Practice Guideline
doi: 10.1159/000443167.
Epub 2016 Jan 5.
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Collaborators,
Affiliations
- PMID: 26731013
- DOI: 10.1159/000443167
Item in Clipboard
Practice Guideline
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
Neuroendocrinology.
2016.
No abstract available
Similar articles
-
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.Neuroendocrinology. 2016;103(2):186-94. doi: 10.1159/000443172. Epub 2016 Jan 5. Neuroendocrinology. 2016. PMID: 26731334 No abstract available.
-
ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.Neuroendocrinology. 2012;95(2):157-76. doi: 10.1159/000335597. Epub 2012 Feb 15. Neuroendocrinology. 2012. PMID: 22262022 No abstract available.
-
[Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):982-986. Zhonghua Wei Chang Wai Ke Za Zhi. 2017. PMID: 28900987 Chinese.
-
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: pre- and perioperative therapy in patients with neuroendocrine tumors.Neuroendocrinology. 2009;90(2):203-8. doi: 10.1159/000225949. Epub 2009 Aug 28. Neuroendocrinology. 2009. PMID: 19713712 No abstract available.
-
Occipital Headache as Initial Manifestation of a Pancreatic Neuroendocrine Tumor.J Gastrointest Cancer. 2018 Dec;49(4):501-503. doi: 10.1007/s12029-017-9931-z. J Gastrointest Cancer. 2018. PMID: 28283989 No abstract available.
Cited by
-
Current status of medical treatment for gastroenteropancreatic neuroendocrine neoplasms and future perspectives.Jpn J Clin Oncol. 2021 Aug 1;51(8):1185-1196. doi: 10.1093/jjco/hyab076. Jpn J Clin Oncol. 2021. PMID: 34038547 Free PMC article. Review.
-
Current and New Challenges in the Management of Pancreatic Neuroendocrine Tumors: The Role of miRNA-Based Approaches as New Reliable Biomarkers.Int J Mol Sci. 2022 Jan 20;23(3):1109. doi: 10.3390/ijms23031109. Int J Mol Sci. 2022. PMID: 35163032 Free PMC article. Review.
-
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients.Eur J Nucl Med Mol Imaging. 2022 Jul;49(9):3203-3214. doi: 10.1007/s00259-022-05734-8. Epub 2022 Mar 1. Eur J Nucl Med Mol Imaging. 2022. PMID: 35230492 Free PMC article.
-
Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting.Adv Ther. 2022 Apr;39(4):1754-1771. doi: 10.1007/s12325-022-02060-1. Epub 2022 Feb 22. Adv Ther. 2022. PMID: 35190997 Free PMC article.
-
Safety and Activity of Metronomic Temozolomide in Second-Line Treatment of Advanced Neuroendocrine Neoplasms.J Clin Med. 2019 Aug 15;8(8):1224. doi: 10.3390/jcm8081224. J Clin Med. 2019. PMID: 31443197 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
